Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
Viking Therapeutics Inc (NASDAQ:VKTX) announced that new clinical data from the company’s VK2735 obesity program were ...
Morningstar13d
Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024
AstraZeneca and TotalEnergies are among the stocks that fell into undervalued territory. We sell different types of products and services to both investment professionals and individual investors ...
Mena FN13d
Congruence Therapeutics Announces Blitz Talk Award And Poster Presentations On MC4R-Deficient Genetic Obesity Program At Obesity Week 2024
today announced two poster presentations at Obesity Week® 2024. In recognition of its innovative research, Congruence has been awarded the Neuroscience Section Blitz Talk Award and will present ...
Yahoo Finance12d
Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024
Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - -Congruence's insights into the biology and ...
Medindia13d
Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024
Title: "Discovery of Small Molecule Correctors for Treatment of Early-onset MC4R-deficient Genetic Obesity"Poster Number: 065Session Date and Time: 11/3/2024, 7.30pm – 8.30pmPresenting Author ...